Lingyan Fei

597 total citations
15 papers, 332 citations indexed

About

Lingyan Fei is a scholar working on Molecular Biology, Nephrology and Surgery. According to data from OpenAlex, Lingyan Fei has authored 15 papers receiving a total of 332 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Nephrology and 3 papers in Surgery. Recurrent topics in Lingyan Fei's work include Cervical Cancer and HPV Research (3 papers), Ovarian cancer diagnosis and treatment (3 papers) and Erythrocyte Function and Pathophysiology (2 papers). Lingyan Fei is often cited by papers focused on Cervical Cancer and HPV Research (3 papers), Ovarian cancer diagnosis and treatment (3 papers) and Erythrocyte Function and Pathophysiology (2 papers). Lingyan Fei collaborates with scholars based in China, Germany and United States. Lingyan Fei's co-authors include Zhihua Zheng, Andreas Patzak, Shangwu Chen, Li Yu, Xubin Liu, Pontus B. Persson, En Yin Lai, Shan Jiang, Liantang Wang and Chun Tang and has published in prestigious journals such as Scientific Reports, Kidney International and Hypertension.

In The Last Decade

Lingyan Fei

13 papers receiving 329 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lingyan Fei China 8 166 98 69 60 45 15 332
Xiaoqiu Ren China 7 141 0.8× 87 0.9× 57 0.8× 37 0.6× 22 0.5× 12 315
Chaosheng Lu China 12 165 1.0× 26 0.3× 56 0.8× 74 1.2× 60 1.3× 23 357
Lele Cheng China 8 186 1.1× 55 0.6× 22 0.3× 70 1.2× 18 0.4× 18 354
Zongwei Lin China 10 204 1.2× 46 0.5× 36 0.5× 29 0.5× 90 2.0× 19 388
Gui Hua Wang China 10 154 0.9× 49 0.5× 31 0.4× 75 1.3× 25 0.6× 19 367
Wenjing Chen China 11 93 0.6× 42 0.4× 23 0.3× 29 0.5× 48 1.1× 28 288
Jieyan Wang China 8 143 0.9× 47 0.5× 37 0.5× 17 0.3× 20 0.4× 33 271
Haowen Jiang China 13 177 1.1× 47 0.5× 109 1.6× 43 0.7× 65 1.4× 29 400
Yoko Mitsuda Japan 10 91 0.5× 48 0.5× 28 0.4× 69 1.1× 19 0.4× 15 358
Eiichiro Satake Japan 10 159 1.0× 45 0.5× 20 0.3× 24 0.4× 101 2.2× 25 348

Countries citing papers authored by Lingyan Fei

Since Specialization
Citations

This map shows the geographic impact of Lingyan Fei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingyan Fei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingyan Fei more than expected).

Fields of papers citing papers by Lingyan Fei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lingyan Fei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingyan Fei. The network helps show where Lingyan Fei may publish in the future.

Co-authorship network of co-authors of Lingyan Fei

This figure shows the co-authorship network connecting the top 25 collaborators of Lingyan Fei. A scholar is included among the top collaborators of Lingyan Fei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lingyan Fei. Lingyan Fei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Tian, Qin, Jinxiang Wang, Qiji Li, et al.. (2025). Branched‐Chain α Keto‐Acid Dehydrogenase Kinase‐Mediated AKT Phosphorylation Promotes RCC Tumorigenesis and Drug Resistance. Advanced Science. 12(40). e11081–e11081.
2.
3.
Fei, Lingyan, Ilka Mathar, Lisa Dietz, et al.. (2024). Activating soluble guanylyl cyclase attenuates ischemic kidney damage. Kidney International. 107(3). 476–491. 9 indexed citations
4.
Wang, Lin, Jinxiang Wang, Ming Pei, et al.. (2024). Future embracing: exosomes driving a revolutionary approach to the diagnosis and treatment of idiopathic membranous nephropathy. Journal of Nanobiotechnology. 22(1). 472–472. 7 indexed citations
5.
Fei, Lingyan, Honghong Wang, Shan Jiang, et al.. (2023). Piezo1 Mediates Vasodilation Induced by Acute Hyperglycemia in Mouse Renal Arteries and Microvessels. Hypertension. 80(8). 1598–1610. 16 indexed citations
6.
Fei, Lingyan, Zhihua Zheng, & Shan Jiang. (2023). Piezo1 Mediates Vasodilation Induced by Acute Hyperglycemia in Mouse Renal Arteries and Microvessels. Journal of the American Society of Nephrology. 34(11S). 497–497. 1 indexed citations
7.
Yu, Li, Xun Chen, Xubin Liu, et al.. (2022). Significance of Triple Detection of p16/ki-67 Dual-Staining, Liquid-Based Cytology and HR HPV Testing in Screening of Cervical Cancer: A Retrospective Study. Frontiers in Oncology. 12. 915418–915418. 4 indexed citations
8.
Fei, Lingyan, Xiaohua Wang, Lei Yan, et al.. (2022). ZIP14 is involved in iron deposition and triggers ferroptosis in diabetic nephropathy. Metallomics. 14(7). 50 indexed citations
9.
10.
Li, Na, Stefanie Steiger, Lingyan Fei, et al.. (2021). IRF8-Dependent Type I Conventional Dendritic Cells (cDC1s) Control Post-Ischemic Inflammation and Mildly Protect Against Post-Ischemic Acute Kidney Injury and Disease. Frontiers in Immunology. 12. 685559–685559. 15 indexed citations
11.
Jiang, Shan, Yongjie Shui, Yu Cui, et al.. (2021). Gut microbiota dependent trimethylamine N-oxide aggravates angiotensin II–induced hypertension. Redox Biology. 46. 102115–102115. 155 indexed citations
12.
Liu, Xubin, Hanyu Ma, Lingyan Fei, et al.. (2020). HPV-mediated down-regulation of NOD1 inhibits apoptosis in cervical cancer. Infectious Agents and Cancer. 15(1). 6–6. 17 indexed citations
13.
Hu, Weipeng, Shan Jiang, Yixin Liao, et al.. (2020). High phosphate impairs arterial endothelial function through AMPK‐related pathways in mouse resistance arteries. Acta Physiologica. 231(4). e13595–e13595. 5 indexed citations
14.
Yu, Li, et al.. (2019). Application of p16/Ki-67 dual-staining cytology in cervical cancers. Journal of Cancer. 10(12). 2654–2660. 47 indexed citations
15.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiaoqiu Ren Breakdown of academic impact, for papers by Chaosheng Lu Breakdown of academic impact, for papers by Lele Cheng Breakdown of academic impact, for papers by Zongwei Lin Breakdown of academic impact, for papers by Gui Hua Wang Breakdown of academic impact, for papers by Wenjing Chen Breakdown of academic impact, for papers by Jieyan Wang Breakdown of academic impact, for papers by Haowen Jiang Breakdown of academic impact, for papers by Yoko Mitsuda Breakdown of academic impact, for papers by Eiichiro Satake
Rankless by CCL
2026